Advertisement
Review Article| Volume 32, ISSUE 2, P303-313, April 2023

Download started.

Ok

Genetic Testing for Adrenal Tumors—What the Contemporary Surgeon Should Know

  • Maria F. Bates
    Affiliations
    Geisel School of Medicine at Dartmouth, Hanover, NH, USA

    Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA

    Section of General Surgery, Division of Endocrine Surgery, One Medical Center Drive, Lebanon, NH 03756, USA
    Search for articles by this author
  • Meredith J. Sorensen
    Correspondence
    Corresponding author.
    Affiliations
    Geisel School of Medicine at Dartmouth, Hanover, NH, USA

    Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA

    Section of General Surgery, Division of Endocrine Surgery, One Medical Center Drive, Lebanon, NH 03756, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hood L.
        • Rowen L.
        The Human Genome Project: big science transforms biology and medicine.
        Genome Med. 2013; 5: 79
        • Rizzo J.M.
        • Buck M.J.
        Key principles and clinical applications of “next-generation” DNA sequencing.
        Cancer Prev Res Phila Pa. 2012; 5: 887-900
        • Fishbein L.
        Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.
        Hematol Oncol Clin North Am. 2016; 30: 135-150
        • Alrezk R.
        • Suarez A.
        • Tena I.
        • et al.
        Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging.
        Front Endocrinol. 2018; 9: 515
        • Patel D.
        • Phay J.E.
        • Yen T.W.F.
        • et al.
        Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
        Ann Surg Oncol. 2020; 27: 1329-1337
        • Li S.R.
        • Nicholson K.J.
        • Mccoy K.L.
        • et al.
        Clinical and Biochemical Features of Pheochromocytoma Characteristic of Von Hippel-Lindau Syndrome.
        World J Surg. 2020; 44: 570-577
        • Gruber L.M.
        • Erickson D.
        • Babovic-Vuksanovic D.
        • et al.
        Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.
        Clin Endocrinol (Oxf). 2017; 86: 141-149
        • Lefebvre M.
        • Foulkes W.D.
        Pheochromocytoma and paraganglioma syndromes: genetics and management update.
        Curr Oncol Tor Ont. 2014; 21: e8-e17
        • Settas N.
        • Faucz F.R.
        • Stratakis C.A.
        Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.
        Mol Cell Endocrinol. 2018; 469: 107-111
        • Plouin P.F.
        • Amar L.
        • Dekkers O.M.
        • et al.
        European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.
        Eur J Endocrinol. 2016; 174: G1-G10
        • Lenders J.W.M.
        • Duh Q.Y.
        • Eisenhofer G.
        • et al.
        Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
        J Clin Endocrinol Metab. 2014; 99: 1915-1942
        • Kim J.H.
        • Kim M.J.
        • Kong S.H.
        • et al.
        Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma.
        J Med Genet. 2022; 59: 56-64
        • Nockel P.
        • El Lakis M.
        • Gaitanidis A.
        • et al.
        Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.
        Surgery. 2018; 163: 191-196
        • Patel D.
        • Phay J.E.
        • Yen T.W.F.
        • et al.
        Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
        Ann Surg Oncol. 2020; 27: 1338-1347
        • Conn J.W.
        The evolution of primary aldosteronism: 1954-1967.
        Harvey Lect. 1966; 62: 257-291
        • Funder J.W.
        • Carey R.M.
        • Mantero F.
        • et al.
        The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
        J Clin Endocrinol Metab. 2016; 101: 1889-1916
        • Mulatero P.
        • Tizzani D.
        • Viola A.
        • et al.
        Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).
        Hypertens Dallas Tex 1979. 2011; 58: 797-803
        • So A.
        • Duffy D.L.
        • Gordon R.D.
        • et al.
        Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.
        J Hypertens. 2005; 23: 1477-1484
        • Fernandes-Rosa F.L.
        • Daniil G.
        • Orozco I.J.
        • et al.
        A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism.
        Nat Genet. 2018; 50: 355-361
        • Choi M.
        • Scholl U.I.
        • Yue P.
        • et al.
        K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
        Science. 2011; 331: 768-772
      1. Melmed S, Polonsky K, Larsen P, Kronenberg H. (2016) Williams Textbook of Endcrinology. 13th edition. Elsevier.

      2. NIH - GTR: Genetic Testing Registry.
        (Available at:) (Accessed July 7, 2022)
        • Geller D.S.
        • Zhang J.
        • Wisgerhof M.V.
        • et al.
        A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.
        J Clin Endocrinol Metab. 2008; 93: 3117-3123
        • Beuschlein F.
        • Fassnacht M.
        • Assié G.
        • et al.
        Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome.
        N Engl J Med. 2014; 370: 1019-1028
        • Salpea P.
        • Stratakis C.A.
        Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.
        Mol Cell Endocrinol. 2014; 386: 85-91
        • Young W.F.
        • Carney J.A.
        • Musa B.U.
        • et al.
        Familial Cushing’s syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later.
        N Engl J Med. 1989; 321: 1659-1664
        • Tirosh A.
        • Valdés N.
        • Stratakis C.A.
        Genetics of micronodular adrenal hyperplasia and Carney complex.
        Presse Medicale Paris Fr 1983. 2018; 47: e127-e137
        • Kirschner L.S.
        • Carney J.A.
        • Pack S.D.
        • et al.
        Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
        Nat Genet. 2000; 26: 89-92
        • Christopoulos S.
        • Bourdeau I.
        • Lacroix A.
        Aberrant expression of hormone receptors in adrenal Cushing’s syndrome.
        Pituitary. 2004; 7: 225-235
        • Assié G.
        • Libé R.
        • Espiard S.
        • et al.
        ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome.
        N Engl J Med. 2013; 369: 2105-2114
        • Charchar H.L.S.
        • Fragoso M.C.B.V.
        An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH).
        J Endocr Soc. 2022; 6: bvac041
        • Bouys L.
        • Chiodini I.
        • Arlt W.
        • et al.
        Update on primary bilateral macronodular adrenal hyperplasia (PBMAH).
        Endocrine. 2021; 71: 595-603
        • Petr E.J.
        • Else T.
        Adrenocortical carcinoma (ACC): When and why should we consider germline testing?.
        Presse Medicale Paris Fr 1983. 2018; 47: e119-e125
        • Else T.
        Association of adrenocortical carcinoma with familial cancer susceptibility syndromes.
        Mol Cell Endocrinol. 2012; 351: 66-70
        • Rodriguez-Galindo C.
        • Figueiredo B.C.
        • Zambetti G.P.
        • et al.
        Biology, clinical characteristics, and management of adrenocortical tumors in children.
        Pediatr Blood Cancer. 2005; 45: 265-273
        • Gatta-Cherifi B.
        • Chabre O.
        • Murat A.
        • et al.
        Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database.
        Eur J Endocrinol. 2012; 166: 269-279
        • Schaefer S.
        • Shipotko M.
        • Meyer S.
        • et al.
        Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
        Eur J Endocrinol. 2008; 158: 699-704
        • Smith T.G.
        • Clark S.K.
        • Katz D.E.
        • et al.
        Adrenal masses are associated with familial adenomatous polyposis.
        Dis Colon Rectum. 2000; 43: 1739-1742
        • Raymond V.M.
        • Everett J.N.
        • Furtado L.V.
        • et al.
        Adrenocortical carcinoma is a lynch syndrome-associated cancer.
        J Clin Oncol Off J Am Soc Clin Oncol. 2013; 31: 3012-3018
        • Ruijs M.W.G.
        • Verhoef S.
        • Rookus M.A.
        • et al.
        TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
        J Med Genet. 2010; 47: 421-428
        • Morioka T.
        • Miyoshi-Imamura T.
        • Blyth B.J.
        • et al.
        Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.
        Cancer Sci. 2015; 106: 217-226